A multifactorial model for ovarian cancer etiology

被引:3
|
作者
von Georgi, R
Münstedt, K
机构
[1] Univ Giessen, Abt Med Soziol, D-35392 Giessen, Germany
[2] Univ Giessen Klinikum, Frauenklin, Giessen, Germany
关键词
ovarian carcinoma; etiology; hypothesis; prognosis; 3DPOK model;
D O I
10.1055/s-2002-35974
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The three major hypotheses that have been formulated to explain the etiology of ovarian cancer are the incessant ovulation hypothesis, the gonadotropin hypothesis, and the inflammation hypothesis. All models were formulated without reference to the others or to psychoneuroimmunologic approaches and psychoneuroendocrinology. We integrated the three hypotheses regarding the pathogenesis of ovarian cancer into a three-dimensional process model (3DPOK model). This model takes into account specific and general risk factors, and the concepts mentioned above. The model combines the different approaches to the etiology of ovarian cancer and illustrates possible relationships between the variables of prevention, treatment and follow-up. It may facilitate the generation of hypotheses for further research.
引用
收藏
页码:1060 / 1068
页数:9
相关论文
共 50 条
  • [41] Spontaneous apoptosis in ovarian cancer: An unfavorable prognostic factor
    Mattern, J
    Stammler, G
    Koomagi, R
    Wallwiener, D
    Kaufmann, M
    Volm, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (02) : 351 - 354
  • [42] A Prognostic Model Based on Metabolism-Related Genes for Patients with Ovarian Cancer
    Dong Jian
    Zhai Lianghao
    Gao Yunge
    Chen Ligang
    Chen Biliang
    Lv Xiaohui
    Doklady Biochemistry and Biophysics, 2023, 510 : 110 - 122
  • [43] A Prognostic Model Based on Metabolism-Related Genes for Patients with Ovarian Cancer
    Dong, Jian
    Zhai, Lianghao
    Gao, Yunge
    Chen, Ligang
    Chen, Biliang
    Lv, Xiaohui
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 510 (01) : 110 - 122
  • [44] Identification of a Novel Prognostic Classification Model in Epithelial Ovarian Cancer by Cluster Analysis
    Chen, Kelie
    Niu, Yuequn
    Wang, Shengchao
    Fu, Zhiqin
    Lin, Hui
    Lu, Jiaoying
    Meng, Xinyi
    Yang, Bowen
    Zhang, Honghe
    Wu, Yihua
    Xia, Dajing
    Lu, Weiguo
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 6251 - 6259
  • [45] Ovarian cancer screening
    Scharf, A
    Günter, HH
    Sohn, C
    GYNAKOLOGE, 2002, 35 (06): : 537 - 547
  • [46] Ovarian cancer in endometriosis
    Konishi, Ikuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 377 - 377
  • [47] Oxaliplatin and ovarian cancer
    Dieras, V
    Girre, V
    Guilhaume, MN
    Laurence, V
    Mignot, L
    BULLETIN DU CANCER, 2006, 93 : S35 - S39
  • [48] Ovarian cancer in endometriosis
    Ikuo Konishi
    International Journal of Clinical Oncology, 2009, 14 : 377 - 377
  • [49] Hereditary ovarian cancer
    Prat, J
    Ribé, A
    Gallardo, A
    HUMAN PATHOLOGY, 2005, 36 (08) : 861 - 870
  • [50] Surgical and Medical Treatment of Clear Cell Ovarian Cancer Results From the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 Retrospective Study
    Magazzino, Francescapaola
    Katsaros, Dionyssios
    Ottaiano, Alessandro
    Gadducci, Angiolo
    Pisano, Carmela
    Sorio, Roberto
    Rabaiotti, Emanuela
    Scambia, Giovanni
    Cormio, Gennaro
    Scarampi, Luca
    Greggi, Stefano
    Savarese, Antonella
    Marinaccio, Marco
    Scollo, Paolo
    Pignata, Sandro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 1063 - 1070